Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 15;12(11):1255–1271. doi: 10.4251/wjgo.v12.i11.1255

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/

PMC Copyright notice

Co-mutation plot of highly frequent mutations in liver cancer. Mutational frequencies are given in a bar plot beside the co-mutation plot. Overall mutation load as the total number of mutations in each patient is presented in the top barplot. Programmed death 1/programmed death ligand 1/programmed death ligand 2 expression is illustrated in a heatmap in the panel below. Clinical data including age, stage, and recurrence event are shown in the top panel. TP53: Tumor suppressor protein p53; CTNNB1: Catenin beta 1; TTN: TITIN; CACNA1E: Calcium voltage-gated channel subunit alpha1 E; RYR: Ryanodine receptor; PD-1: Programmed death 1; PD-L1: Programmed death ligand 1; PD-L2: Programmed death ligand 2.